NASDAQ:NRC - Get Free Report ) shares hit a new 52-week low on Thursday . The stock traded as low as $29.58 and last traded at $29.58, with a volume of 837 shares. The stock had previously closed at $29.76.
Get National Research alerts:
Sign Up
Analysts Set New Price Targets Separately, TheStreet lowered shares of National Research from a "b-" rating to a "c+" rating in a research note on Thursday, January 11th.
Read Our Latest Research Report on NRC
National Research Price Performance The stock has a market cap of $685.80 million, a price-to-earnings ratio of 23.19 and a beta of 0.45. The company's 50 day moving average is $36.90 and its 200 day moving average is $39.13. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.67 and a quick ratio of 0.67.
National Research (NASDAQ:NRC - Get Free Report ) last announced its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share (EPS) for the quarter. The company had revenue of $38.00 million for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%.
National Research Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be paid a $0.12 dividend. The ex-dividend date is Friday, June 28th. This represents a $0.48 annualized dividend and a yield of 1.67%. National Research's payout ratio is currently 38.71%.
Institutional Investors Weigh In On National Research A number of hedge funds and other institutional investors have recently made changes to their positions in the business. iA Global Asset Management Inc. acquired a new stake in shares of National Research during the 3rd quarter worth $11,124,000. Comerica Bank acquired a new stake in National Research during the 3rd quarter valued at approximately $6,939,000. Norden Group LLC acquired a new stake in National Research in the first quarter valued at $5,170,000. PineStone Asset Management Inc. increased its position in shares of National Research by 128.9% in the 4th quarter. PineStone Asset Management Inc. now owns 153,100 shares of the company's stock worth $6,057,000 after purchasing an additional 86,202 shares during the last quarter. Finally, Conestoga Capital Advisors LLC lifted its position in shares of National Research by 6.0% during the third quarter. Conestoga Capital Advisors LLC now owns 773,215 shares of the company's stock worth $34,308,000 after purchasing an additional 43,475 shares during the last quarter. Hedge funds and other institutional investors own 47.26% of the company's stock.
About National Research (
Get Free Report )
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Further Reading Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
